공시 • Mar 03
Craneware plc Declares Interim Dividend for the Six Months Ended 31 December 2025, Payable on 16 April 2026 Craneware plc announced the board has declared an interim dividend of 15.0 pence per ordinary share (20.25 cents per ordinary share) for the six months ended 31 December 2025 (H1 FY25: 13.5 pence per ordinary share (16.87 cents per ordinary share)). The interim dividend is payable on 16 April 2026 to those shareholders on the register as at 20 March 2026. The ex-dividend date is 19 March 2026. The interim dividend of 15 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who has registered to do so by the close of business on 20 March 2026. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 20 March 2026. 공시 • Jan 20
Craneware plc to Report First Half, 2026 Results on Mar 02, 2026 Craneware plc announced that they will report first half, 2026 results on Mar 02, 2026 공시 • Nov 22
Craneware plc Announces Board Changes As previously announced, following many years of service on the Board of Directors, David Kemp, Senior Non-Executive Director, has decided not to stand for re-election at the Company's AGM later 21 November 2025 and as a result, will retire from the Board following the close of the meeting. The Board thanks him for his significant contributions during his tenure. His insight and constructive challenge have been invaluable, helping drive Craneware's success. Following the completion of the AGM, Alistair Erskine will assume the role of Senior Independent Director, Susan Nelson will assume the role of Chair of the Audit Committee and Jill Goldsmith will take over the role of Company Secretary to the Board. 공시 • Sep 16
Craneware plc Recommends Final Dividend for the Year Ended 30 June 2025, Payable on 18 December 2025 Craneware plc recommended final dividend for the year ended 30 June 2025 of 18.5 pence per share (FY24: 16.0 pence per share), resulting in a proposed total dividend for the year of 32.0 pence per share (FY24: 29 pence per share). Subject to shareholder approval at the Annual General Meeting, the final dividend is expected to be paid on 18 December 2025 to those on the register as at 28 November 2025, with the corresponding ex-dividend date of 27 November 2025. The final dividend of 18.5 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who register to do so by the close of business on 28 November 2025. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 28 November 2025. 공시 • Jul 16
Craneware plc to Report Fiscal Year 2025 Results on Sep 15, 2025 Craneware plc announced that they will report fiscal year 2025 results on Sep 15, 2025 공시 • Jun 12
Bain Capital Intends Not to Make an Offer for Craneware Further to the announcement on 16 May 2025 regarding a possible offer for Craneware plc (AIM:CRW) ("Craneware"), Bain Capital Private Equity (Europe), LLP ("Bain Capital"), in its capacity as an adviser to the funds managed and/or advised by it or its affiliates (the "Bain Capital Funds"), confirmed that it does not intend to make a firm offer for Craneware. This is a statement to which Rule 2.8 of the Code applies. Accordingly, Bain Capital and any person(s) acting in concert with it will, except with the consent of the Panel on Takeovers and Mergers (the "Takeover Panel"), be bound by the restrictions set out in Rule 2.8 of the Code. Under Note 2 of Rule 2.8 of the Code, Bain Capital, and any person(s) acting in concert with it, reserves the right to set the restrictions in Rule 2.8 of the Code aside in the following circumstances: a) with the agreement of the Board of Directors of Craneware; b) following the announcement of a firm intention to make an offer for Craneware by, or on behalf of, a third party; c) following the announcement by Craneware of a Rule 9 waiver proposal (as described in Note 1 of the Notes on Dispensations from Rule 9 of the Code), or a reverse takeover (as defined by the Code); or d) where the Takeover Panel has determined that there has been a material change in circumstances. Bain Capital also reserves the right to acquire shares of Craneware, subject to, and in accordance with, the Code and other applicable regulations. 공시 • Jun 11
Bain Capital Private Equity (Europe), LLP cancelled the acquisition of Craneware plc (AIM:CRW). Bain Capital Private Equity (Europe), LLP proposed to acquire Craneware plc (AIM:CRW) for approximately £940 million on May 16, 2025. Bain Capital confirms that the Bain Capital Funds are assessing a possible offer to acquire the issued and to be issued share capital of Craneware. This evaluation is highly preliminary in nature, and has not to date involved any approach to the Board of Craneware. The Board of Craneware confirms that no proposal has been received from Bain Capital.
Khamran Ali and Nick Harper of Goldman Sachs International acted as financial advisor for Craneware plc. Neil Patel, Michael Nicholson, Benjamin Cryer and Kate Bannatyne of Peel Hunt LLP acted as financial advisor for Craneware plc.
Bain Capital Private Equity (Europe), LLP cancelled the acquisition of Craneware plc (AIM:CRW) on June 11, 2025. The Board confirms that it rejected a proposal from Bain Capital that valued Craneware at £26.50 per share, a price which the Board believes fundamentally undervalues Craneware and its prospects. The proposal was received without the parties entering into a due diligence process. The Board believes that the proposal received from Bain is not in the best interest of shareholders and is not consistent with the Board's understanding of the objectives of shareholders. The Board believes the Company's share price performance over the last 12 months is not reflective of the Company's trading performance and the continued improving prospects of the business, instead reflecting non-Craneware specific market factors. Bain Capital Private Equity (Europe), LLP also confirms that it does not intend to make a firm offer for Craneware. 공시 • Mar 12
Craneware plc Declares an Interim Dividend, Payable on 17 April 2025 The Board of Craneware plc has declared an interim dividend of 13.5 pence (16.87 cents) per ordinary share, payable on 17 April 2025 to those shareholders on the register as at 21 March 2025 (FY24 Interim dividend 13.0 pence). The ex-dividend date is 20 March 2025. The interim dividend of 13.5 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who has registered to do so by the close of business on 21 March 2025. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 21 March 2025. The interim dividend referred to above in US dollars of 16.87 cents is given as an example only using the Balance Sheet date exchange rate of $1.25/£1 and may differ from that finally announced. 공시 • Nov 13
Craneware plc Announces Board and Committee Changes Craneware plc announced, following many years' service on the Board of Directors, Colleen Blye, Senior Non-Executive Director, and Russ Rudish, Non-Executive Director, are not standing for re-election at the Company's AGM later on 13 November 2024. The company announced the appointment of Tamra Minnier as Non-Executive Director, which will take effect following 13 November 2024 AGM. Tamra is an experienced senior US healthcare executive, currently holding the role of Senior Vice President, Health Services Division, and Chief Quality and Operational Excellence Officer for UPMC. Tamra's role includes overseeing the Wolff Center, the driving force for Quality and Safety, Nursing, Surgical Services, Pharmacy, Imaging and Laboratory Operations for UPMC and responsibility for The Beckwith Institute. Following the completion of the AGM, David Kemp, will assume the role of Senior Independent Director, as well as continuing his role as Chair of the Audit Committee; Alistair Erskine will assume the role of Chair of the Remuneration Committee, and the appointment of Tamra Minnier will come into effect. Tamra E. Minnier, aged 62, has been a director or partner of the following companies or partnerships during the five years preceding the date of this announcement: Current: The United Way of Southwestern Pennsylvania; Phipps Conservatory and Botanical Gardens Inc.; Aging Institute; Infectious Disease Connect Inc. and The United Way of Western Pennsylvania. Historic: Joint Commission Resources Inc. and Patient Safety Movement Foundation. New Risk • Oct 27
New minor risk - Dividend sustainability The dividend is not well covered by earnings. Payout ratio: 110% Dividend yield: 1.6% This is considered a minor risk. Companies that pay out too much of their earnings are at risk of having to reduce or cut their dividend in future. If earnings growth slows or earnings fall, then there may not be enough earnings to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. However, this risk is mitigated by the fact the dividend is covered by cash flows. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (110% payout ratio). Significant insider selling over the past 3 months (€12m sold). Reported Earnings • Oct 20
Full year 2024 earnings released: EPS: US$0.34 (vs US$0.26 in FY 2023) Full year 2024 results: EPS: US$0.34 (up from US$0.26 in FY 2023). Revenue: US$189.3m (up 8.8% from FY 2023). Net income: US$11.7m (up 27% from FY 2023). Profit margin: 6.2% (up from 5.3% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. 공시 • Oct 18
Craneware plc, Annual General Meeting, Nov 13, 2024 Craneware plc, Annual General Meeting, Nov 13, 2024. Location: the offices of craneware plc, 1 tanfield, eh3 5da, edinburgh United Kingdom Recent Insider Transactions • Sep 13
Co-Founder recently sold €11m worth of stock On the 11th of September, Keith Neilson sold around 424k shares on-market at roughly €26.02 per share. This transaction amounted to 12% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Keith's only on-market trade for the last 12 months. Buy Or Sell Opportunity • Sep 06
Now 22% overvalued Over the last 90 days, the stock has fallen 2.2% to €26.60. The fair value is estimated to be €21.75, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 21% over the last 3 years. Earnings per share has declined by 11%. For the next 3 years, revenue is forecast to grow by 8.2% per annum. Earnings are also forecast to grow by 26% per annum over the same time period. Declared Dividend • Sep 05
Final dividend of UK£0.16 announced Shareholders will receive a dividend of UK£0.16. Ex-date: 28th November 2024 Payment date: 18th December 2024 Dividend yield will be 1.2%, which is higher than the industry average of 0.9%. Sustainability & Growth Dividend is covered by both earnings (89% earnings payout ratio) and cash flows (50% cash payout ratio). The dividend has increased by an average of 7.5% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 90% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Sep 04
Full year 2024 earnings released: EPS: US$0.34 (vs US$0.26 in FY 2023) Full year 2024 results: EPS: US$0.34 (up from US$0.26 in FY 2023). Revenue: US$189.3m (up 8.8% from FY 2023). Net income: US$11.7m (up 27% from FY 2023). Profit margin: 6.2% (up from 5.3% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe. 공시 • Jul 18
Craneware plc to Report Fiscal Year 2024 Results on Sep 03, 2024 Craneware plc announced that they will report fiscal year 2024 results on Sep 03, 2024 Reported Earnings • Mar 06
First half 2024 earnings released: EPS: US$0.12 (vs US$0.11 in 1H 2023) First half 2024 results: EPS: US$0.12 (up from US$0.11 in 1H 2023). Revenue: US$91.2m (up 7.7% from 1H 2023). Net income: US$4.06m (up 3.4% from 1H 2023). Profit margin: 4.5% (down from 4.6% in 1H 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.7% p.a. on average during the next 3 years, compared to a 9.1% growth forecast for the Healthcare Services industry in Europe. 공시 • Mar 05
Craneware plc Declares Dividend, Payable on April 15, 2024 The Board of Craneware plc declared a dividend of 13.0 pence (16.51 cents) per ordinary share, payable on 15 April 2024 to those shareholders on the register as at 22 March 2024 (Fiscal year 2023 Interim dividend 12.5 pence). The ex-dividend date is 21 March 2024. The interim dividend of 13.0 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who has registered to do so by the close of business on 22 March 2024. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 22 March 2024. The interim dividend referred to above in US dollars of 16.51 cents is given as an example only using the Balance Sheet date exchange rate of $1.27/£1 and may differ from that finally announced. 
